It is proposed here that NMO and progressive MS might rely on the following opposite molecular mechanisms: an acutely-defective AQP4/TGFB1 pathway in NMO versus a chronically-stimulated AQP4/TGFB1 pathway in progressive MS (Figure 1). Here, TGFB1 is linked to myeloid sarcoma.